Abstract:Two recent pivotal studies offer an opportunity to shift the thinking on population strategies to reduce dietary sodium intake to improve cardiovascular health. The SSaSS (Salt Substitute and Stroke Study), a cluster-randomized controlled study in high-risk persons in rural China was the first randomized clinical trial in a community setting of dietary sodium reduction with a potassium enriched salt substitute to report a reduction not only in blood pressure, but, in stroke, heart disease events, and total mortality. 1 The sodium intervention was a potassium-enriched salt substitute and was provided for food preservation and food preparation in homes in individuals with high risk for cardiovascular disease. See related article, pp 2188–2198 A second pivotal study is reported in this issue of Hypertension. 2 The researchers modeled the effects of a population-wide intervention in India replacing salt with a potassium enriched salt substitute as used in the China study. The modeling study evaluated the impact of this intervention on cardiovascular disease morbidity and mortality as well as adverse effects from hyperkalemia both in the general population and in those with undiagnosed chronic kidney disease. A similar modeling study was performed on the Chinese population as a follow-up of the SSaSS study. 1 Results from the India study suggest that nation wide salt substitution could prevent 8% to 14% of cardiovascular events annually (240 000–315 000 lives saved per year in the total population). While intervention strategies have focused on reducing sodium intake, the importance of increasing potassium needs consideration, both the potential for harm from hyperkalemia and whether increased potassium intake reduces cardiovascular disease risk. Concern about the possibility of hyperkalemia with the use of potassium-enriched salt substitutes has likely reduced enthusiasm for its use as a population strategy to lower blood pressure and reduce cardiovascular disease risk. The SSaSS study addressed this issue carefully, evaluating reports of risk and benefit of the intervention in the general population. Importantly, the India study evaluated both risk and benefit in persons with undiagnosed chronic kidney disease. The India modeling study demonstrates a strong benefit in those with and without chronic kidney disease. The small morbidity and mortality from hyperkalemia in the chronic kidney disease group is overwhelmed by the large benefit on cardiovascular health. In the SSaSS study, as well as most studies on the effect of potassium-enriched salt substitutes on blood pressure, the focus has been on the benefit of sodium reduction. Sorting out the potential contribution of increasing potassium intake in these studies has been a matter of interest for decades. 3 Increasing potassium intake without lowering sodium intake has a modest effect on lowering blood pressure. In the early 1990s, Langford 4 raised the question of whether there was cardiovascular protection from potassium independent of the effect on blood pressure. Since then, multiple studies have identified the benefit of higher potassium intake along with sodium reduction lowering blood pressure as well as the risk of cardiovascular disease, especially stroke. 3 Understanding the relative contribution of decreasing dietary sodium versus increasing dietary potassium could be important in designing interventions for future studies and in clinical implementation. Another key issue, study design, will be considered in deciding whether these 2 studies dramatically shift thinking on adopting potassium-enriched salt substitution as a population strategy for cardiovascular disease prevention. The study from India is a modeling study using the most rigorous methods for this study design. Modeling studies have gained widespread acceptance under certain circumstances including the inability to perform a trial in humans. 5 However, some scientists, clinicians, and policy makers are not willing to consider modeling studies as definitive evidence to support clinical decisions among individuals or policy making at the population level. The China study was conducted in a single country in a high-risk population, so generalizability is a consideration. Thus, some might hesitate to embrace these 2 studies as pivotal. The ideal follow-up to the China study would be to conduct randomized controlled trials in the general population (as opposed to a high risk group) of various countries. If possible, this approach would satisfy current thinking of regulators on necessary evidence. In the late 20th century and early 21st century, regulatory agencies overseeing cardiovascular medication approval declared that demonstrating improvement in the risk factors ("soft end points") was no longer sufficient to dec -Abstract Truncated-

Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study

Potassium-Enriched Salt Substitution as a Population Strategy to Prevent Cardiovascular Disease

Salt Substitution: A Low-Cost Strategy for Blood Pressure Control among Rural Chinese. A Randomized, Controlled Trial

Effect of Salt Substitution on Cardiovascular Events and Death.

Dietary Intakes of Hypertensive Patients in Rural India: Secondary Outcomes of a Randomised, Double-Blind, Controlled Trial

Effect of salt substitution on community-wide blood pressure and hypertension incidence

Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): the protocol for a double-blinded, randomized-controlled trial.

The Proportion of Dietary Salt Replaced With Potassium-Enriched Salt in the SSaSS: Implications for Scale-Up

Effects and individual response of salt substitute intervention on blood pressure in a high-risk stroke population: findings from 4200 participants of the China Salt Substitute and Stroke Study

Potassium-Enriched Salt Substitutes: A Review of Recommendations in Clinical Management Guidelines

Interim Effects of Salt Substitution on Urinary Electrolytes and Blood Pressure in the China Salt Substitute and Stroke Study (Ssass)

The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study

Effects of Salt Substitutes on Clinical Outcomes: a Systematic Review and Meta-Analysis

Urinary Sodium Excretion, Blood Pressure, Cardiovascular Disease, and Mortality: a Community-Level Prospective Epidemiological Cohort Study.

Effects of Salt Substitute on Pulse Wave Analysis among Individuals at High Cardiovascular Risk in Rural China: a Randomized Controlled Trial.

Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults

Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS)

Long-Term Effect of Salt Substitute on All-Cause and Cardiovascular Disease Mortality: An Exploratory Follow-Up of a Randomized Controlled Trial

The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern China

Cost-Effectiveness of a Household Salt Substitution Intervention: Findings from 20 995 Participants of the Salt Substitute and Stroke Study

Projected effect of dietary salt reductions on future cardiovascular disease.